Use of GM-CSF in the treatment of colitis associated with chronic granulomatous disease.
Wang
Julie
J
Mayer
Lloyd
L
Cunningham-Rundles
Charlotte
C
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003092:Colitis / Q000188:drug therapy* / Q000209:etiology*; D004359:Drug Therapy, Combination; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006105:Granulomatous Disease, Chronic / Q000150:complications*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor